Pharmacogenomics Market : Future Growth Prospects for Major Leaders by 2027

 

Pharmacogenomics Market

Market Synopsis:

As per Market Research Future (MRFR)’s analysis, the global pharmacogenomics market is set to expand at a CAGR of 5.8% during the forecast period. It is a new development in the field of medical science and aims at developing effective and safe medications. This, in turn, has enabled it to gain much popularity in a short span of time, thus, augmenting the market.

Pharmacogenomics is expected to facilitate the treatment of a wide spectrum of diseases such as cardiovascular diseases, Alzheimer disease, cancer, HIV/AIDS, and asthma among others. An upsurge in the investments for technology advancements is primarily poised to revolutionize the pharmacogenomics market Furthermore, it also supports the customization of medicine doses according to a person’s genetics. This, in turn, has led to an expansion of the market presence of pharmacogenomics throughout the global healthcare sector.

The biotechnology industry has been burgeoning, and it has paved the way for the growth of the pharmacogenomics market in the recent time. A similar trend is likely to be witnessed in the upcoming years by the market participants. On the flip side, a lack of awareness about the technology and inconsistency in the products are presumed to hold the proliferation of the pharmacogenomics market over the next couple of years.

Competitive Dashboard:

Some of the key players profiled in this report are Myriad Genetics, Inc. (U.S.), GeneTech (U.S.), GeneDx. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), 23andMe, Inc. (U.S.), Future Science Group (U.S.), Assurex Health, Inc. (U.S.), and Pathway Genomics (U.S.).

Get Sample Report: https://www.marketresearchfuture.com/sample_request/1177

Market Segmentation:

On the basis of technology, the global pharmacogenomics market has been segmented into microarray, sequencing, polymerase chain reaction, and others. The sequencing segment has been further sub-segmented into Sanger sequencing, pyrosequencing, next-generation sequencing, and others.

On the basis of application, the pharmacogenomics market has been segmented into oncology, cardiology, neurological disorders, and others. The oncology segment has been sub-segmented into breast cancer, lung cancer, and others.

On the basis of end-users, the global pharmacogenomics market has been segmented into hospitals, research organizations, academic institute, and others

Regional Analysis:

The global pharmacogenomics market, by region, has been segmented into Americas, Europe, Asia Pacific, and the Middle East & Africa. Americas is expected to dominate the global market owing to the presence of developed economies and an advanced healthcare sector. Furthermore, the increasing patient pool of cardiovascular diseases and rising healthcare expenditure is poised to boost the growth trajectory of the pharmacogenomics market.

Europe is presumed to command the second-largest market share during the forecast period. The primary factors that are expected to complement the growth of the regional pharmacogenomics market include availability of findings, increasing research & development activities, and growing support by the government. Also, the consolidation of major country-level markets such as Germany and France are poised to reflect positively on the expansion of the market.

Asia Pacific resonates strong potential for expansion. It has been projected to become the fastest growing regional pharmacogenomics market over the assessment period. Meanwhile, the Middle East & Africa is set to exhibit sluggish growth. The laggards restricting the growth of the pharmacogenomics market in the region are low per capita healthcare expenditure and stringent government policies, especially in the African region.

Access Report Details: https://www.marketresearchfuture.com/reports/pharmacogenomics-market-1177

Industry News:

In December 2018, a leading telegenomics technology and services company, Genome Medical, has added pharmacogenomics to its line of genetic services.

In December 2018, ZibdyHealth has become the first health application to make pharmacogenomics simple to use, easy to understand, and useful for everyone by integrating clinical and genomic data.

In December 2018, Genesys Physicians Hospital Organization, a leader in genomics and precision medicine, has selected 2bPrecise pharmacogenomics (PGx) solution for improving medication safety and overall patient care.

In December 2018, OneOme, co-developed by Mayo Clinic, has announced that it has received approval from New York State Department of Health for offering pharmacogenomic testing.

Related Report: Global Human Insulin Market Research Report - forecast to 2027

 

Global Wearable Medical Device Market Research Report - Forecast to 2027

 

Global Circulating Tumor Cell Market Research Report- Forecast To 2027

 

Global Medical Holography Market Research Report- Forecast To 2027

 

Microspheres Market Research Report - Forecast 2027

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

 

Contact:

 

Market Research Future®

 

99 Hudson Street,5Th Floor

 

New York, New York 10013

 

United States of America

 

Phone:

 

+1 628 258 0071(US)

 

+44 2035 002 764(UK)

 

Email: sales@marketresearchfuture.com

 

Website: https://www.marketresearchfuture.com

 

 

 

 

Comments

Post a Comment

Popular posts from this blog

Dry Age-Related Macular Degeneration Market Size, Share, Application Analysis, Regional Outlook, Growth Trends, Competitive Strategies

Image
  Dry Age-Related Macular Degeneration Market This degenerative eye disease is caused by the thinning of the macula and interferes with a clear vision in the elderly. The macula is part of the retina that facilitates clear vision; when this part of the eye deteriorates, it causes blurred or distorted vision. But this does not mean that the individual will lose his or her sight, only the central vision is affected by this degenerative disease, and the peripheral vision remains intact. Vision loss is slow and can be corrected using innovative ocular treatments. It has been estimated that the Dry Age-Related Macular Degeneration Market has seen a jump due to increased research in drugs, rising amount of COVID-19 cases among the old and age-restricted chronic diseases.   The dry age-related macular degeneration AMD market is expected to cross USD 15,351.07 million by 2027 at a CAGR of 8.20% during the forecast period   List of Key Companies Covered...
Read more

Cardiopulmonary Resuscitation Market: Innovations and Trends Shaping Life-Saving Techniques

  Introduction Cardiopulmonary Resuscitation (CPR) stands as a vital life-saving technique that has transformed emergency healthcare. As the cornerstone of effective response to cardiac arrest, the CPR market has been witnessing remarkable advancements driven by technology, research, and innovation. This article delves into the evolving landscape of the Cardiopulmonary Resuscitation Market, highlighting its trends, innovations, and impact on global healthcare. CPR: A Lifeline in Critical Moments Cardiopulmonary resuscitation, commonly referred to as CPR, is a crucial technique employed to sustain blood circulation and provide oxygen to the brain during cardiac arrest. It involves chest compressions and, in some cases, rescue breaths to maintain oxygen levels until professional medical assistance arrives. CPR significantly increases the chances of survival when performed promptly and correctly. Market Growth and Trends The CPR market has been experiencing steady growth due to incre...
Read more

Pain Management Devices Market Set To Exhibit Strong Growth, Valuable Research Factors and Industry Forecast to 2030

Image
  Pain Management Devices Market – Overview The Pain Management Devices Market can anticipate expansion at a rate of 7.12% from 2020 to 2030, believes MRFR (Market Research Future). Progress in technology and better research capabilities have led to the development of devices that can control pain with limited use of drugs. Focused Market reports connected to the healthcare sector among others lately have been made available by Market Research Future which publishes a report on this sector. The development of pain management devices has been useful to control pain in a wide range of ailments. The level of relief from pain that is experienced, is one of the major driving factors for the industry, as patients who use such devices are prone to chronic pain daily. Cancer patients and the geriatric population are among the major user segments for the pain management devices as medication alone may not be sufficient to provide pain relief in their situation. The industry is antici...
Read more